We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $23B Turnover 30.09%
1-Year Est. Return 30.41%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
-4.82%
1 Year Est. Return
+30.41%
3 Year Est. Return
+123.44%
5 Year Est. Return
+128.94%
10 Year Est. Return
+270.39%
AUM
$24.8B
AUM Growth
+$7.6B
Cap. Flow
+$8.89B
Cap. Flow %
35.82%
Top 10 Hldgs %
33.94%
Holding
992
New
259
Increased
549
Reduced
155
Closed
24
Avg Time Held
0.8 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
2.6 years

Top Sells

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$40M
2
HD icon
Home Depot
HD
+$38.9M
3
JD icon
JD.com
JD
+$35.3M
4
GLD icon
SPDR Gold Trust
GLD
+$31.6M
5
TSLA icon
Tesla
TSLA
+$26.9M

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.83%
2 Miscellaneous 21.28%
3 Healthcare 18.15%
4 Consumer Discretionary 13.79%
5 Technology 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VWO icon
1
Vanguard FTSE Emerging Markets ETF
VWO
$107B
$1.05B 4.22%
22,717,958
+5,912,598
+35% +$284M
2013 Q2
35 quarters
PG icon
2
Procter & Gamble
PG
$393B
$1.04B 4.2%
6,823,611
+1,634,471
+31% +$256M
2020 Q3
6 quarters
IEMG icon
3
iShares Core MSCI Emerging Markets ETF
IEMG
$129B
$887M 3.57%
15,960,820
+7,668,119
+92% +$443M
2016 Q3
22 quarters
EEM icon
4
iShares MSCI Emerging Markets ETF
EEM
$25B
$886M 3.57%
19,621,771
+10,710,521
+120% +$505M
2013 Q2
35 quarters
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$851M 3.43%
1,883,234
– –
2013 Q2
35 quarters
BABA icon
6
Alibaba
BABA
$202B
$814M 3.28%
7,480,545
+3,212,150
+75% +$370M
2018 Q2
15 quarters
JNJ icon
7
Johnson & Johnson
JNJ
$651B
$770M 3.1%
4,345,002
+1,247,260
+40% +$212M
2020 Q3
6 quarters
KO icon
8
Coca-Cola
KO
$417B
$740M 2.98%
11,937,821
+3,247,047
+37% +$197M
2020 Q3
6 quarters
PEP icon
9
PepsiCo
PEP
$192B
$698M 2.81%
4,171,268
+1,119,392
+37% +$188M
2020 Q3
6 quarters
COST icon
10
Costco
COST
$488B
$684M 2.76%
1,187,767
+272,132
+30% +$143M
2020 Q1
8 quarters
WMT icon
11
Walmart
WMT
$1.02T
$600M 2.42%
12,096,117
+3,600,546
+42% +$169M
2020 Q3
6 quarters
MCD icon
12
McDonald's
MCD
$193B
$571M 2.3%
2,309,303
+631,903
+38% +$157M
2020 Q3
6 quarters
IVV icon
13
iShares Core S&P 500 ETF
IVV
$802B
$510M 2.05%
1,123,267
+249,645
+29% +$112M
2013 Q2
35 quarters
GLD icon
14
SPDR Gold Trust
GLD
$118B
$381M 1.54%
2,107,996
-180,399
-8% -$31.6M
2017 Q2
19 quarters
ABT icon
15
Abbott
ABT
$178B
$360M 1.45%
3,045,430
+861,685
+39% +$107M
2020 Q3
6 quarters
SBUX icon
16
Starbucks
SBUX
$118B
$300M 1.21%
3,299,256
+738,610
+29% +$69.7M
2020 Q1
8 quarters
TGT icon
17
Target
TGT
$75.1B
$281M 1.13%
1,323,118
+274,310
+26% +$59.3M
2020 Q1
8 quarters
MDT icon
18
Medtronic
MDT
$128B
$209M 0.84%
+1,880,088
New +$199M
2022 Q1
0 quarters
CL icon
19
Colgate-Palmolive
CL
$78.5B
$199M 0.8%
2,627,436
+728,497
+38% +$57.7M
2020 Q3
6 quarters
PDD icon
20
Pinduoduo
PDD
$119B
$198M 0.8%
4,939,412
+2,277,541
+86% +$117M
2019 Q2
11 quarters
EL icon
21
Estee Lauder
EL
$36B
$197M 0.8%
724,888
+212,329
+41% +$63.9M
2020 Q3
6 quarters
PFE icon
22
Pfizer
PFE
$156B
$172M 0.69%
3,314,055
+2,581,384
+352% +$134M
2021 Q1
4 quarters
ISRG icon
23
Intuitive Surgical
ISRG
$138B
$159M 0.64%
526,494
+125,702
+31% +$36.7M
2020 Q3
6 quarters
BIDU icon
24
Baidu
BIDU
$21.1B
$149M 0.6%
1,126,473
+376,604
+50% +$56.8M
2018 Q2
15 quarters
SYK icon
25
Stryker
SYK
$118B
$148M 0.6%
552,227
+139,070
+34% +$36M
2020 Q1
8 quarters

Similar funds

Ray Dalio's Q1 2022 Portfolio in Review

As of Q1 2022, Ray Dalio held 992 positions worth $24.8B, up 44% from $17.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ray Dalio deployed $8.89B of net new capital in Q1 2022, opening 259 new positions and adding to 549 existing holdings. Its largest new stake was Medtronic: 1,880,088 shares worth $209M.

By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 28% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Lowe's Companies, an estimated $40M trimmed.

  • Ray Dalio's largest Q1 2022 buy was Medtronic: 1,880,088 shares worth $209M.
  • Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $505M increase.
  • Ray Dalio's biggest Q1 2022 reduction was Lowe's Companies, cutting an estimated $40M.
  • Ray Dalio fully exited Tesla in Q1 2022, selling an estimated $26.9M.
  • Ray Dalio's ten largest holdings make up 34% of its $24.8B portfolio in Q1 2022.
  • Ray Dalio opened 259 new positions and closed 24 in Q1 2022.
  • Ray Dalio's portfolio value rose 44% quarter-over-quarter to $24.8B.

Based on Bridgewater Associates's 13F filing for Q1 2022, filed 13 May 2022.